Guaifenesin 200 mg/Phenylephrine Hydrochloride 5 mg per 5 mL | GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE

15:44 EDT 7th July 2015 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Guaifenesin 200 mgPhenylephrine hydrochloride 5 mg

ExpectorantNasal Decongestant

Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus, drain bronchial tubes, and make coughs more productive. Temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies (allergic rhinitis). Temporarily relieves nasal stuffiness. Helps decongest sinus openings and passages; temporarily relieves sinus congestion and pressure.

Do not exceed recommended dosage. If nervousness, dizziness, or sleeplessness occurs, discontinue use and consult a doctor. If symptoms do not improve within 7 days or are accompanied by fever, consult a doctor.

A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache, consult a doctor.

Do not take this product for persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, or where cough is accompanied by excessive phlegm (mucus) unless directed by a doctor.

Do not take this product if you have heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland unless directed by a doctor.

Do not use if you are now takin g a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

ask a health professional before use.

In case of accidental overdose, seek professional assistance, or contact a Poison Control Center immediately.

Adults and children 12 years of age and over: 10 mL every 4 hours, not to exceed 6 doses in 24 hours. Children 6 to under 12 years of age: 5 mL every 4 hours, not to exceed 6 doses in 24 hours. Children 2 to under 6 years of age: 2.5 mL every 4 hours, not to exceed 6 doses in 24 hours. Children under 2 years of age: Consult a physician.

Store at 20°-25°C (68°-77°F).

aspartame, bittermask, citric acid, glycerin, ethyl maltol, methylparaben, potassium citrate, potassium sorbate, propylene glycol, propylparaben, purified water, FD&C red #40, strawberry cream flavor, and sucrose.

Call 1-866-934-6025

IMAGE label.jpg

Manufacturer

River’s Edge Pharmaceuticals, LLC

Active Ingredients

Source

Drugs and Medications [1418 Associated Drugs and Medications listed on BioPortfolio]

Phenylephrine guaifenesin [River's Edge Pharmaceuticals, LLC]

RE Phenylephrine 1.5 mg/Guaifenesin 20 mg Drops

Healthy accents tussin cf [DZA Brands LLC]

DZA Brands, LLC Tussin CF Drug Facts

Rx act tussin cf [H E B]

HEB Tussin CF Cough and Cold Drug Facts

Tussin cf [HyVee Inc]

Hy-Vee, Inc. Tussin CF Drug Facts

Leader tussin cf [Cardinal Health]

Cardinal Health Tussin CF Drug Facts

Clinical Trials [1266 Associated Clinical Trials listed on BioPortfolio]

Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers

This study will evaluate the safety of phenylephrine hydrochloride 10 mg + acetaminophen 500 mg + dimethindene maleate 1 mg compared to phenylephrine hydrocloride 10 mg alone in healthy vo...

Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(COMPLETED)

This is a randomized, two-way crossover, multicenter study evaluating the consumer preference of Phenylephrine Extended Release Tablets, 30 mg to be taken as one tablet every 12 hours, or ...

The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study

This is a 14-day, randomized, placebo-controlled, parallel group, masked clinical trial of oral guaifenesin for the therapy of Chronic Rhinitis in 36 children between the ages of 7 and 18 ...

Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)

This study will assess the food-effect bioavailability of an extended release formulation of phenylephrine HCl and its bioequivalence to the marketed immediate release phenylephrine HCl pr...

A Randomized, Double-Blind, Trial Comparing Epinephrine Versus Phenylephrine as a Vasoconstrictor in Regional Anesthesia for Upper Extremity Surgery

The study involves research, the purpose of which is to compare three different drug mixtures (Epinephrine, Phenylephrine 25 µg, or Phenylephrine 50 µg). Specifically, how long each med...

PubMed Articles [258 Associated PubMed Articles listed on BioPortfolio]

Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.

Topical phenylephrine hydrochloride is routinely administered with few safety precautions, but evidence regarding its systemic safety to date is controversial. As even short-term variations in 24-hour...

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study.

Phenylephrine hydrochloride (PE HCl) is widely used for the treatment of nasal congestion, but efficacy at the 10-mg dose is not known for certain. The Food and Drug Administration has requested that ...

The Differential Pupillary Response to 2.5% Phenylephrine in Patients Taking Tamsulosin.

Purpose: To determine if a pharmacological test could be developed to determine iris dilator dysfunction in patients taking tamsulosin. Methods: Patients taking tamsulosin and controls were recruited ...

Acute Psychotic Symptoms due to Benzydamine Hydrochloride Abuse with Alcohol.

Benzydamine hydrochloride is a locally acting nonsteroidal anti-inflammatory drug. Benzydamine hydrochloride overdose can cause stimulation of central nervous system, hallucinations, and psychosis. We...

A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.

To evaluate the long-term safety of oxycodone-hydrochloride and sequestered naltrexone-hydrochloride (ALO-02) administered for up to 12 months.


Advertisement
 

Relevant Topics

Respiratory
Latest News Clinical Trials Research Drugs Reports Corporate
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Allergies
Latest News Clinical Trials Research Drugs Reports Corporate
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Advertisement
 

Drugs and Medication Quicklinks


Searches Linking to this Drug Record